KOREA ARLICO PHARM CO.,LTD.KOREA ARLICO PHARM CO.,LTD.KOREA ARLICO PHARM CO.,LTD.

KOREA ARLICO PHARM CO.,LTD.

No trades
See on Supercharts

260660 fundamentals

KOREA ARLICO PHARM CO.,LTD. key financial stats and ratios

260660 price-to-sales ratio is 0.34. The company has an Enterprise Value to EBITDA ratio of 69.71. As of 2024 they employed 242 people.

Statistics
Q1 '17
Q2 '17
Q3 '17
Q4 '17
Q1 '18
Q2 '18
Q3 '18
Q4 '18
Q1 '19
Q2 '19
Q3 '19
Q4 '19
Q1 '20
Q2 '20
Q3 '20
Q4 '20
Q1 '21
Q2 '21
Q3 '21
Q4 '21
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Price to earnings ratio
Price to cash flow ratio
Currency: KRW
Q1 '17
Q2 '17
Q3 '17
Q4 '17
Q1 '18
Q2 '18
Q3 '18
Q4 '18
Q1 '19
Q2 '19
Q3 '19
Q4 '19
Q1 '20
Q2 '20
Q3 '20
Q4 '20
Q1 '21
Q2 '21
Q3 '21
Q4 '21
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Current
Key stats
Valuation ratios
Profitability ratios
Liquidity ratios
Solvency ratios